J&J's shares fell 5.8% despite an earnings beat and raised guidance, as MedTech weakness, drug sales shortfalls and acquisition costs weighed on results.
J's MESH role deepens its U.K. energy-transition exposure as it supports a 300MW/55GWh project with over 190 hours of storage.
Jacobs Solutions (J) reported earnings 30 days ago. What's next for the stock?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
J pairs record backlog and higher guidance with margin gains, but debt and execution risks keep the investment case balanced.
J is expanding its AI infrastructure role beyond data centers, with record backlog and broader project exposure supporting its next growth phase.
J's 11.5% rally is backed by record backlog, AI-driven demand and higher guidance, but valuation and execution remain key watchpoints.
J's Q3 revenues top estimates as record backlog and AI-related infrastructure demand support growth, even as the stock fell after results.
Jacobs Solutions NYSE: J reported fiscal third-quarter 2026 results marked by organic revenue growth, margin expansion and a record backlog, prompting the company to raise its full-year outlook for the third consecutive quarter.
Jacobs Solutions Inc. (J) Q3 2026 Earnings Call Transcript